PICA CONSORTIUM

The Pharmacogenomics in Childhood Asthma (PiCA) consortium is a research consortium that has been established in December 2013 by prof. dr. Anke-Hilse Maitland van der Zee and dr. Susanne Vijverberg to bring together asthma studies that have genetic data and treatment outcome measures. Asthma is the most common chronic disease in childhood. Although it cannot be cured, effective treatments are available. However, there is a large variability in treatment response which is partly due to genetic variances... Welcome to the website of the Pharmacogenomics in Childhood Asthma consortium. We aim to bring academic experts in the field of personalized medicine for childhood asthma together and stimulate innovation.